Cours Purple Biotech Ltd. TEL AVIV STOCK EXCHANGE
Actions
PPBT
IL0007650166
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 14,87 M 56,6 M 13,58 M |
---|---|---|---|---|---|
Résultat net 2024 * | - | Résultat net 2025 * | - | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,59% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gil Efron
CEO | Chief Executive Officer | 57 | 11/10/18 |
Lior Fhima
DFI | Director of Finance/CFO | - | 02/11/22 |
Ido Morpurgo
COO | Chief Operating Officer | 51 | 01/08/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Eric Rowinsky
CHM | Chairman | 67 | 02/10/19 |
Yael Margolin
BRD | Director/Board Member | 70 | 20/12 |
Simcha Rock
BRD | Director/Board Member | 73 | 11/07/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |